Literature DB >> 20169809

Race, stability of health insurance coverage, and prescription medication use.

Karen P Winters1, Sharon B Wyatt, Todd G Nick, Peggy O Hewlett, John C Hyde, Audwin B Fletcher.   

Abstract

OBJECTIVE: To determine the effects of health insurance and race on prescription medication use and expense.
METHODS: An observational, non-experimental design was used. Multivariable regression analyses were conducted to evaluate the independent effects of health insurance status and race on prescription medication use and expense while controlling for sociodemographic, geographic, and health status characteristics. The sample consisted of 19,035 participants in the 1996 through 2003 Medical Expenditure Panel Survey.
FINDINGS: European Americans spent about $300 to $400 more and used three to four more prescriptions annually compared to other racial groups. Prescription medication expenses increased as time spent uninsured increased. Participants with part-year coverage filled four fewer prescriptions than those with full-year health insurance coverage. Participants with private coverage spent less on prescription medications compared to those with public and those with dual public and private coverage ($1,194 vs. $1,931 and $2,076, respectively; p < or = 0.001).
CONCLUSIONS: Significant racial and health insurance status disparities in prescription medication use and expenses exist after controlling for sociodemographic, geographic, and health status characteristics.

Entities:  

Mesh:

Year:  2010        PMID: 20169809

Source DB:  PubMed          Journal:  ABNF J        ISSN: 1046-7041


  3 in total

1.  Predicting adolescents' persistence, non-persistence, and recent onset of nonmedical use of opioids and stimulants.

Authors:  Brandon Nakawaki; William D Crano
Journal:  Addict Behav       Date:  2012-02-17       Impact factor: 3.913

2.  Changing Diagnostic and Treatment Criteria for Chronic Illness: A Critical Consideration of their Impact on Low-Income Hispanic Patients.

Authors:  Linda M Hunt; Meta Kreiner; Fredy Rodriguez-Mejia
Journal:  Hum Organ       Date:  2013

Review 3.  Disparity implications of the Medicare medication therapy management eligibility criteria: a literature review.

Authors:  Kiraat D Munshi; Ya-Chen T Shih; Lawrence M Brown; Samuel Dagogo-Jack; Jim Y Wan; Junling Wang
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2013-04       Impact factor: 2.217

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.